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Abstract 
To improve the biological properties of calcium phosphate (CaP) bone substitute, new chemical compositions 
are under development. In vivo such materials are subject to degradation that could lead to particles release and 
inflammatory reactions detrimental to the bone healing process. This study aimed at investigating the 
interactions between a murine macrophage cell line (RAW 264.7) and substituted hydroxyapatite particles 
presenting promising biological properties. Micron size particles of stoichiometric and substituted 
hydroxyapatites (CO3 substitution for PO4 and OH; SiO4 substitution for PO4; CO3 and SiO4 co-substitution) 
were obtained by aqueous precipitation followed by spray drying. Cells, incubated with four doses of particles 
ranging from 15 to 120 µg/mL, revealed no significant LDH release or ROS production, indicating no apparent 
cytotoxicity and no oxidative stress. TNF-α production was independent of the chemistry of the particles; 
however the particles elicited a significant dose-dependent pro-inflammatory response. As micron size particles 
of these hydroxyapatites could be at the origin of inflammation, attention must be paid to the degradation 
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behavior of substituted hydroxyapatite bone substitute in order to limit, in vivo, the generation of particulate 
debris. 
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1. Introduction 
The number of patients undergoing surgical bone reconstruction after trauma, cancer or malformations 
significantly increases (Planell et al. 2009). Surgery procedures mainly involve the use of autografts, allografts 
or xenografts. However, these options suffer from many disadvantages like morbidity and limited availability for 
the autografts or risks of rejection for the allografts and the xenografts (Oryan et al. 2014). To bridge this gap 
and to meet these drawbacks, synthetic bone substitutes have been developed since the 80s. Among them, 
calcium phosphate (CaP) based materials, such as hydroxyapatite (HA) and beta-tricalcium phosphate (β-TCP), 
present a high chemical similarity with the mineral component of bone (Rey et al. 2009) as well as an excellent 
biocompatibility with human tissues (Dorozhkin et al. 2002). They have been implanted clinically for more than 
30 years either in the form of porous block or granules to fill bone defect, but also as a coating of metallic part of 
prostheses to promote their osteointegration (Campana et al. 2014). 
Following the implantation of HA or β-TCP biomaterial, biological and biochemical process occur at the 
implant-tissue interface, such as biomaterial degradation and release of ions, protein adsorption and cell 
adhesion. These key events, that govern the appositional bone growth and its quality, are affected by the 
physiological environment at the implantation site (e.g. perfusion, pH, loading) as well as by the intrinsic 
properties of the biomaterial such as its solubility, permeability or wettability (Bouet et al. 2015). The in vivo 
degradation of CaP based biomaterial results from cell-mediated resorption, through the generation of an acidic 
extracellular compartment surrounding the material, and from chemical dissolution in physiological medium 
(Detsch et al. 2008; Raynaud et al. 2002). In vivo studies have shown that particulate debris can be released 
during the degradation of CaP bioceramics (Benhayoune et al. 2000; Hing et al. 2007; Lu et al. 2004). In 
addition to destabilize the early bone apposition, these debris can cause adverse immunogenic responses 
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orchestrated by cells of the monocyte/macrophage lineage that impair the natural bone healing process (Hing et 
al. 2007; Lu et al. 2004). Once debris are phagocytosed, pro-inflammatory mediators are released including 
tumor necrosis factor-alpha (TNF-α), interleukin IL-1β and IL-6 (Curran et al. 2005; Lange et al. 2009; Lange et 
al. 2011; Laquerriere et al. 2003; Velard et al. 2013). As some of these cytokines are involved in the 
differentiation of the bone resorbing osteoclasts cells (Lange et al. 2009), they can impair the balance between 
bone formation and resorption. In this context, particles of CaP based materials, like HA, β-TCP or biphasic 
calcium phosphate, have been proved to elicit a pro-inflammatory response in vivo (Hing et al. 2007) and in vitro 
using various cell lines (Curran et al. 2005; Lange et al. 2009; Lange et al. 2011; Laquerriere et al. 2003; 
Ninomiya et al. 2001; Zhang et al. 2012).  
Ideally, CaP bone graft materials should provide a framework for bone growth and be degraded only when the 
woven bone tissue became a mature bone tissue (Heljak et al. 2012). The ability of CaP materials to be degraded 
and to foster the bone ingrowth is highly dependent on their chemical composition. For instance, HA displays a 
low rate of biodegradation as compared to β-TCP that is highly soluble (Barralet et al. 2000; Detsch et al. 2008). 
Moreover, HA shows limited ability to stimulate the development of new bone tissue (Porter et al. 2005; Spence 
et al. 2010). Thus, the performances of currently available synthetic biomaterials (HA and β-TCP) are not fully 
optimal for regenerative medicine. To further improve their biological properties, ionic substitutions into the HA 
crystal lattice are investigated (Shepherd et al. 2012). Among the ionic groups of biological interest, carbonate 
and silicate appear to be promising candidates to improve the biological properties of HA. 
Literature has reported the beneficial effect of carbonate substitution for phosphate and/or hydroxide in HA. In 
vivo data have shown the formation of higher amount of new and mature bone into porous implant of carbon-
substituted hydroxyapatite (CHA) than into HA (Landi et al. 2003). Moreover, the incorporation of carbonate 
into HA increases its solubility (Barralet et al. 2000; Porter et al. 2005) and its osteoclastic resorption in a dose-
dependent manner (Spence et al. 2010; Spence et al. 2009). In addition, it is well known that silicon plays an 
essential role in bone metabolism (Carlisle 1970; Carlisle 1972). At physiological levels, soluble silicon was 
found to enhance osteoblastic cells differentiation (Reffitt et al. 2003) and to increase the bone mineral density 
(Jugdaohsingh 2007). That is why silicon-substituted hydroxyapatite (SiHA) is expected to improve the bone 
growth rate and quality over HA and has been widely studied over the last few years (Marchat et al. 2013). 
Carbon- and silicon-substituted hydroxyapatite (CSiHA) could represent an interesting co-substitution. Indeed, 
this CO3 and SiO4 co-substitution into HA may result in a synergy between the CHA biodegradation properties 
and the release of soluble silicate. To date, very few studies deal with the elaboration and the biological 
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evaluation of CSiHA. However, Landi et al. (2010) have indicated that for low amount of silicon (0.55 wt.%), 
CSiHA is not toxic for human osteoblasts. Solubility of CSiHA is greater than that of HA samples and is 
accompanied “by silicon ions release” (Bang et al. 2014; Pavankumar 2011). Even though CHA, SiHA and 
CSiHA bioceramics appear biocompatible in their bulk form, a lack of knowledge remains concerning the effects 
of debris released through their degradation. Thus, the present study is a preliminary work whose aim is to 
investigate the in vitro toxicity and pro-inflammatory response of these hydroxyapatites particles by means of 
macrophage cell line. To avoid a potential size or shape effect, substituted hydroxyapatite particles with similar 
morphologies were prepared. To this aim, powders with well-controlled chemical composition were synthetized 
via a wet precipitation method and the particles were shaped by spray drying. Their physical properties were 
adjusted by means of specific thermal treatment depending on their chemical compositions. The biological 
responses they induce were then evaluated regarding several parameters: Lactate Dehydrogenase (LDH) release 
(reflecting the integrity of the cell membrane), Tumor Necrosis Factor alpha (TNF-α) production (to assess the 
inflammatory response) and the production of different Reactive Oxygen Species (ROS). 
 
2. Material and methods 
2.1. Chemical synthesis of substituted hydroxyapatite particles 
Four types of particles differing by their chemistry were studied: hydroxyapatite (HA), carbon-substituted 
hydroxyapatite (CHA), silicon-substituted hydroxyapatite (SiHA) and carbon-silicon co-substituted 
hydroxyapatite (CSiHA). They were prepared according to the following theoretical formulas : Ca10(PO4)6(OH)2 
for HA, Ca10(PO4)5.6(SiO4)0.4(OH)1.6 for SiHA, Ca9.2(PO4)5.2(CO3)0.8(OH)1.2 for CHA and 
Ca9.6(PO4)4,8(CO3)0.8(SiO4)0.4(OH)1.6 for CSiHA. The powders were synthesized through an aqueous precipitation 
method according to a protocol that has been developed for the synthesis of monophasic SiHA with controlled 
stoichiometry (Boyer et al. 2013; Marchat et al. 2013). Briefly, a diammonium hydrogen phosphate aqueous 
solution ((NH4)2HPO4, 99%, Merck, Germany), and, if applicable, an ammonium hydrogen carbonate aqueous 
solution ((NH4)HCO3, 99%, Merck, Germany) and an alkaline silicate solution were added to a calcium nitrate 
aqueous solution (Ca(NO3)2, 4H2O, 99%, Merck, Germany) maintained under stirring. The reactions were 
performed under argon flow. The pH of the suspension was adjusted (at 9.5 for HA, 8.0 for CHA, 11.0 for SiHA 
and 10.8 for CSiHA) by the addition of a 28% ammonia solution (Merck, Germany) by means of a dosing pump 
(ProMinent, Germany) coupled with a pH controller and sensor. The temperature was regulated at 50°C for HA, 
SiHA and CSiHA and 65°C for CHA with an external T-probe connected to a cryothermostat (Huber, Germany). 
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Suspensions were matured for 24 h, centrifuged at 1500 rpm for 5 min (Thermo Scientific, France) to eliminate 
the excess of ammonia solution and resuspended in distilled water. The resulting suspensions were then spray 
dried (Büchi B290, Germany) and finally, a thermal treatment under a specific atmosphere, depending on the 
chemistry, was applied (Table 1).  
2.2. Physico-chemical characterization of substituted hydroxyapatite particles 
Crystalline phases were identified using a Siemens D5000 θ/2θ X-ray diffractometer using CuKα radiation. 
Diffractograms with a step size of 0.02° and a counting time of 9 s by step were acquired. Standard patterns from 
International Center for Diffraction Data – Powder Diffraction Files (ICDD-PDF) were used for phase 
identification. Fourier transform infrared (FTIR) spectroscopy measurements were carried using a MIR TF 
Vertex 70 Spectrometer by means of the ATR system. Collected spectra over the range 4000–400 cm-1 were 
normalized from the ν4 band of the phosphate group at 600 cm-1 as usual (Rey et al. 1989). 
The silicon contents were determined using Inductively Coupled Plasma Atomic Emission Spectrometry 
(ICP/AES) (Spectrometer HORIBA, Jobin-Yvon, with Activa model) after dissolution of the samples in nitric 
acid solution. The carbon contents were measured using an elemental analyzer with an infrared detector (Leco 
CS-444 carbon and sulfur analyzer). All these analyses were performed in triplicate. 
Morphology of the particles were observed using Scanning Electron Microscopy (SEM JEOL 6500 F). Samples 
were prepared by dispersing the particles in absolute ethanol. After sonication at 40 W for 5 min (Branson 
Sonifier) a drop of the suspension was deposited on a carbon-coated film and sputtered with gold (Quorum, 
Q150RES, England). The specific surface areas (SSA) were determined by N2 adsorption after out-gassing for 
12 h at 110°C (Micromeritics ASAP 2020) using the Brunauer–Emmet–Teller (BET) 5 points method. The 
particle size range was analyzed by laser diffraction method (Mastersizer 2000, Malvern). A suspension of 
particles was prepared with a dispersant (Darvan® C, Vanderbilt Minerals) and then sonicated at 40 W for 5 min 
(Branson Sonifier) before analysis. 
2.3. Cell culture and cells-particles contact 
Prior to suspension preparation, the particles were treated at 210°C for 30 min to sterilize the samples and to 
avoid the presence of endotoxins that may result in measurement bias. The suspensions were prepared in culture 
medium: Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen) complemented with 10% of fetal calf 
serum (FCS, Invitrogen), 1% penicillin-streptomycin (penicillin 10,000 U/mL, streptomycin 10 mg/mL; Sigma-
Aldrich, France). Particle concentrations of 15, 30, 60 and 120 µg/mL were used for the toxicity assays. A stock 
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solution at 120 µg/mL was dispersed by sonication at 40 W for 5 min (Branson Sonifier) and then diluted to 
obtain the other particles concentrations. All the suspensions were kept at 4°C and used in the following 48 h. 
Biological assays were carried out using the RAW 264.7 cell line, provided by ATCC Cell Biology Collection 
(Promochem LGC, France) and derived from mice peritoneal macrophages transformed by the Albeson Murine 
Leukemia Virus. Cells, seeded at 100,000 cells/well, were prepared in 96-well plates in 50 µL of complemented 
DMEM and were allowed to adhere overnight at 37°C in a 5% CO2 humidified atmosphere. 150 µL of particles 
suspensions were added to the culture and incubated for 90 min or 24 h. A negative control was performed 
incubating cells alone (without particles). 
2.4. Cellular morphology 
Cells incubated with particles for 24 h were gently removed with a scraper, deposited on glass plates and 
cytocentrifuged for 10 min at 400 rpm (Cytospin Shandon). Samples were air dried over night at room 
temperature before a May Grunwald Giemsa staining (MGG). Optical images were acquired with Leica DM750. 
2.5. Cellular membrane integrity  
Cytotoxicity was evaluated by quantifying the Lactate Dehydrogenase (LDH) released in culture supernatant 
from cells with damaged membranes. After a 24 h incubation with particles, the CytoTox-96® Non-radioactive 
Cytotoxicity Assay (Promega) was used according to the manufacturer’s instructions. To obtain the positive 
control, 20 µl of 10X lysis solution provided by the manufacturer was added 45 min before analysis. Detection 
was performed using a microplate reader (Multiskan GO, Thermo Scientific) at 490 nm. The activity of the 
released LDH was reported as a percentage of the total cellular LDH (measured after the lysis of control cells). 
2.6. Pro-inflammatory response 
After 24 h incubation with particles, Tumor Necrosis Factor alpha (TNF-α) production was assessed using a 
commercial ELISA kit (Quantikine® Mouse TNF-α Immunoassay, R&D systems) according to the 
manufacturer’s instructions. The optical density of each well was determined using a microplate reader 
(Multiskan GO, Thermo Scientific) set to 450 nm. A standard curve was established and results were expressed 
in pg of TNF-α per mL of supernatant. 
2.7. Oxidative stress  
Oxidative stress was estimated by measuring the intracellular ROS level using the OxiSelect™ Intracellular ROS 
Assay Kit (Cell Biolabs) after 90 min (for acute oxidative stress evaluation) and 24 h incubation with the 
particles. The assay employs the conversion by ROS of a non-fluorescent substrate, 2’,7’-
Dichlorodihydrofluorescin diacetate (DCFH-DA), which can easily diffuse through cell membranes into a 
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molecule DCF (2’, 7’-Dichlorodihydrofluorescein) which is highly fluorescent and amount of which is 
proportional to total ROS. A 1 h pre-treatment with the cell-permeant DCFH-DA was carried out before particles 
incubation. The fluorescence intensities were read at 480 nm excitation and 530 nm emission (Fluoroskan 
Ascent, Thermo scientific). Results were expressed in nM of DCF produced per hour. 
2.8. Statistical analysis 
Results were expressed as the mean of three independent experiments carried out in quadruplets, with standard 
errors of the mean value (SEM). Statistical significance was declared when p<0.05 using a Bonferroni post-test 
after a two-way ANOVA. 
 
3. Results 
3.1. Physico-chemical features of substituted hydroxyapatite particles 
After thermal treatment (Table 1), the particles displayed only the crystalline phase matching the ICDD standard 
for hydroxyapatite (HA, PDF 9-432) as shown by the XRD patterns (Fig. 1). No other crystalline phase was 
detected. The IR spectra of the samples (Fig. 2) exhibited intense bands characteristic of hydroxyapatite with the 
ν2 (473 cm-1), ν4 (560 and 602 cm-1), ν1 (960 cm-1) and ν3 (1015 – 1030 and 1085 cm-1) modes of PO43-, as well 
as the librational (νL: 629 cm-1) and stretching (νS: 3572 cm-1) modes of the hydroxyl groups. Depending on the 
composition, other specific bands are noticeable. Spectra of particles synthesized in the presence of carbonates 
ions (i.e. CHA and CSiHA) exhibited bands, in the range 650-900 cm-1 and 1350-1600 cm-1, characteristic of the 
incorporation of carbonate in HA structure (Lafon et al. 2008). These bands were assigned either to carbonate 
vibrations in A site (i.e. substituting for hydroxyl groups) or B site (i.e. substituting for phosphate groups) of the 
apatite. Spectra of SiHA and CSiHA samples displayed specific bands or shoulders attributed to SiO4 in HA 
structure at 505 cm-1 (ν2), 525 cm-1 (ν4), 752 cm-1 (ν1) and 891 cm-1 (ν3) and 925 cm-1 (Si-OH) (Marchat et al. 
2013). The presence of carbon and silicon in the samples was confirmed by elemental analysis (Table 1). As 
expected, the amount of carbon in CHA and CSiHA were similar, 1.2 and 1.3 wt. % respectively, as well as the 
amount of silicon in SiHA and CSiHA, 1.3 and 1.2 wt. % respectively. No traces of silicon was detected in HA 
and CHA samples. Traces of carbon measured in HA and SiHA were due to adsorbed carbon dioxide. After 
thermal treatment, the particles exhibited round shape morphologies (Fig. 3) with specific surface areas ranging 
from 14.5 to 21.6 m²/g (Table 1). Whatever the chemistry, the sample displayed similar monodisperse particle 
size distribution in the 0.8 – 10.0 µm range (Fig. 4).  
3.2. In vitro cellular response 
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3.2.1. Cellular morphology 
Cells incubated for 24 h with particles have been observed after MGG staining. Representative optic microscopy 
images for the highest dose of particles are presented in Fig. 5. Cells with a lysed membrane and condensed 
nucleus were dead cells. They were identified in a same amount on the control as on the cells incubated with 
particles. Whatever the particle chemistry is, macrophages morphology after exposure to particles was similar to 
that of control cell. Images showed that particles were preferentially located in the cytoplasm periphery of the 
cells, close to the membrane surface. No clear evidence of the presence of vesicle was noticed. 
3.2.2. Cell membrane integrity 
Extracellular LDH directly correlates with the rate of cell membrane damage, since this enzyme is 
physiologically present in the cytoplasm. After incubation of the cells with the particles, the release of LDH was 
similar to that measured for the negative control (cells alone, Fig. 6). Moreover, no significant dose-response 
relationship was observed.  
3.2.3. Pro-inflammatory response 
All the particles exhibited significantly higher TNF-α production than the negative control (Fig. 7). At 
concentrations of 15 and 30 µg/mL, the particles induced similar pro-inflammatory responses. From 30 µg/mL, 
levels of TNF-α released in media significantly increased with the concentration of particles to reach around 
850 pg/mL for a particle dose of 120 µg/mL, whatever the chemistry is. 
3.2.4. Oxidative stress 
The oxidative stress was determined by the ROS production. For a given time of exposure, levels of ROS were 
similar for all the particles chemistries and were twice higher at 24 h than at 90 min (Fig. 8). However, values 
were significantly lower than for the positive control (cells incubated with 1 mM of H2O2), whatever the 
experimental conditions (i.e. chemistry or particle dose) are. 
 
4. Discussion 
Particles of carbon- and/or silicon-substituted HA were prepared by adjusting a wet precipitation method 
conventionally used to synthesize substituted calcium phosphate powders (Marchat et al. 2013; Raynaud et al. 
2002). Depending on their chemistry, the particles were heat treated at a specific temperature and under a 
specific atmosphere (Table 1). The XRD data showed that after thermal treatment, all the particles were 
monophasic. The CO2 atmosphere used during the heat-treatment of carbon containing samples (i.e. CHA and 
CSiHA) allowed to maintain carbonate ions in the apatite lattice and to avoid phase decomposition (Boyer et al. 
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2013; Lafon et al. 2003). FTIR spectra of CHA and CSiHA revealed that carbonate substitution occurred on both 
phosphate and hydroxyl sites. As a consequence, intensities of hydroxyl groups for these samples logically 
decreased as compared to HA sample. In a same way, for SiHA sample, the decrease of intensity of the band for 
OH group was attributed to the creation of OH vacancies resulting from the incorporation of SiO4 into HA 
structure (Marchat et al. 2013). Therefore, monophasic particles of stoichiometric and carbon and/or silicon 
substituted HA were produced and used for further biological experiments.  
Shanbhag et al. (1994) proved that, additionally to chemistry, macrophages were sensitive to the surface 
developed by the particles present in the cell culture. In the present study, weight concentrations of spherical 
particles ranging from 15 to 120 µg/mL were used. As their specific surface area were in a same order of 
magnitude (Table 1), comparison between the different chemistries was possible. Moreover, particle sizes were 
in the range of the micron with a D50 around 2 µm. This size range was consistent with the size of particulate 
debris observed in in vivo studies from retrieved tissues (Benhayoune et al. 2000; Hing et al. 2007; Lu et al. 
2004). The studied particles were in a clinically relevant range. Although it has been noted that particles were 
released from CaP based materials in vivo, no quantitative information on the particle number was reported in 
the above mentioned studies. Thus, it is difficult to address a direct correspondence between in vivo and in vitro 
studies. However, the particle concentrations used were comparable to the concentrations used in similar in vitro 
experiments (Lange et al. 2009; Pioletti et al. 2000; Zhang et al. 2012) and covered two orders of magnitude. 
After implantation of a bone substitute, since a biomaterial is considered as a foreign body, the natural host 
response leads to the recruitment from the blood of monocytes which become macrophages (Anderson et al. 
2008). Thus, the present biological evaluation was performed on macrophages that are, moreover, the major cells 
responsible for mediating the pro-inflammatory response to implant debris (Ingham et al. 2005). RAW 264.7 cell 
lines were selected due to their active role in an inflammatory response model and their activations and functions 
have been well established (Salitsky 1983). Data presented here revealed an absence of ROS generation by the 
macrophage, irrespective of the chemistry of the particles. The release of LDH was similar to that of the negative 
control, revealing no cytotoxicity. These results were consistent with the microscopic observations (Fig. 5) 
which revealed that, even for high dose of particles, cells presented morphology comparable to that of control 
cells.  
The results also showed that substituted hydroxyapatite particles can trigger the production of the TNF-α 
cytokine by macrophage RAW 264.7. The inflammatory effect was dose-dependent, but no influence of SiO4 
and/or CO3 substitution into HA was noticed. So, the chemistry of the studied particles did not induce changes in 
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TNF-α production. Lange et al. (2009) came to the same conclusion after studying HA and β-TCP particles of 
the same size incubated with human peripheral blood mononuclear cells: the particles elicited similar production 
of proinflammatory cytokines (TNF-α, IL-β and IL-8). However, the chemistry of CaP based materials highly 
influenced their dissolution behavior and, as a consequence, their ability to heal a bone defect. Indeed, an in vivo 
study, performed in a standard rabbit defect model, has shown that the poor performance of β-TCP biomaterials 
can be assigned to its high solubility that induced an early loss of integrity of the implant and of the bone 
apposition along with a proinflammatory response provoked by the release of particulate debris (Hing et al. 
2007). This immunogenic response would be a consequence of the presence of high amount of β-TCP particles. 
This statement is supported in vitro by Zhang et al. (2012) who reported a 3-fold increase of the amount of 
TNF-α release by osteocytes-like cells when the concentration of β-TCP particles increases from 100 to 
1000 µg/mL. Besides, TNF-α produced by macrophages may stimulate the expression of RANKL (Receptor 
Activator of Nuclear factor Kappa-B Ligand) and M-CSF (Macrophage Colony Stimulating Factor), together 
involved in the differentiation of osteoclast precursors into mature osteoclasts that resorb bone (Ingham et al. 
2005). So, it clearly appears that, to efficiently heal a bone defect, the generation of particulate debris from the 
bioceramics must be restricted. It implies to adjust the degradation behavior of the current CaP materials in order 
to reach an intermediate behavior between that of HA and β-TCP, while having a material that at least, supports 
or even favors the bone apposition. These are the expected characteristics of CSiHA composition that contains 
carbonate (to control the rate of resorption and dissolution) and silicate (supposed to increase the early bone 
apposition) in substitution into HA. As the pro-inflammatory response is particle dose-dependent, further studies 
to characterize the degradation of CSiHA ceramics in vivo and in vitro are under progress and will be interpreted 
in the light of the present data. A complementary way to adjust the degradation behavior of CaP bone substitutes, 
especially for the challenging field of large bone defect reconstruction, would be to control their manufacturing 
process (i.e. shaping and sintering) in order to maintain the integrity of the bioceramic and to avoid a premature 
in vivo degradation. The recent advances in additive manufacturing technics coupled to computational models 
give opportunities to develop new designs of implants with complex architecture allowing maximizing the ratio 
between mechanical strength and degradation rate (Heljak et al. 2012). 
 
5. Conclusion  
In summary, micron sized particles composed of carbon- and/or silicon-substituted hydroxyapatite exhibited no 
in vitro toxicity for macrophages RAW 264.7. An equivalent dose-dependent pro-inflammatory response was 
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observed whatever the ionic substitution (CO3 substitution for PO4 and OH; SiO4 substitution for PO4 or CO3 
and SiO4 co-substitution) is. These results provide evidence that for these compositions, between the chemistry 
and the particles concentration, the in vitro immunogenic response was mainly due to the latter. This conclusion 
should now be confirmed by in vivo experiments. Moreover, as the cytokine released by macrophage can alter 
the bone remodeling process, accurate evaluation of the degradation of these CaP bone substitutes must be 
performed to confirm their performance. 
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Table 
Table 1. Thermal treatment applied to the calcium phosphate particles and their resulting physico-chemical 
characteristics  
Particle 
chemistry 
Thermal treatment 
Carbon content  / 
wt.% 
Silicon content  / 
wt.% 
Specific surface 
area  / m².g
-1
 
HA 800°C for 1 h under air 0.08 ± 0.01 0 20.6 ± 0.1 
CHA 800°C for 2 h under CO2  1.21 ± 0.02 0 14.5 ± 0.3 
SiHA 890°C for 2 h under air 0.08 ± 0.01 1.3 ± 0.4 21.6 ± 0.2 
CSiHA 870°C for 1 h under CO2  1.33 ± 0.02 1.2 ± 0.4 20 ± 0.2 
 
 
Figures 
 
Fig. 1 X-Ray Diffraction patterns of calcium phosphate particles 
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Fig. 2 FTIR spectra of calcium phosphate particles 
 
 
Fig. 3 Scanning Electron Microscopy images of calcium phosphate particles 
 
 
Fig. 4 Particle size distribution of the calcium phosphate suspensions 
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Fig. 5 Morphology of RAW 264.7 cells exposed for 24 h to 120 µg/mL of particles after May Grünwald Giemsa 
staining. Controls are macrophages incubated alone or particles of CSiHA at 120 µg/mL incubated alone; stars 
indicate dead cells and arrows indicate particles 
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Fig. 6 Cytotoxicity determined by LDH release after 24 h exposure of RAW 264.7 cells with different dose of 
particles reported to that of total cellular LDH measured after the lysis of control cells (n = 3, *** p < 0.001) 
 
 
Fig. 7 Proinflammatory response determined by TNF-α production and measured after 24 h exposure of RAW 
264.7 cells with different dose of particles (n = 3, *** p < 0.001, ** p < 0.01) 
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Fig. 8 Oxidative stress determined by ROS production after 90 min (a) and 24 h (b) exposure of RAW 264.7 
cells with different dose of CaP particles (n = 3, *** p < 0.001). Results are expressed in nM/h of 2’,7’-
dichlorohidrofluorescein (DCF) 
 
 
